1. A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol. (October 2019) Authors: Rabe, Klaus F.; Martinez, Fernando J.; Ferguson, Gary T.; Wang, Chen; Singh, Dave; Wedzicha, Jadwiga A.; Trivedi, Roopa; St Rose, Earl; Ballal, Shaila; McLaren, Julie; Darken, Patrick; Reisner, Colin; Dorinsky, Paul Journal: Respiratory medicine Issue: Volume 158(2019) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An overview of glycopyrrolate/eFlow® CS in COPD. (3rd June 2018) Authors: Kerwin, Edward; Ferguson, Gary T. Journal: Expert review of respiratory medicine Issue: Volume 12:Number 6(2018) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. (August 2021) Authors: Martinez, Fernando J.; Rabe, Klaus F.; Ferguson, Gary T.; Wedzicha, Jadwiga A.; Trivedi, Roopa; Jenkins, Martin; Darken, Patrick; Aurivillius, Magnus; Dorinsky, Paul Journal: Respiratory medicine Issue: Volume 185(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study. Issue 3 (16th September 2018) Authors: Ferguson, Gary T.; Papi, Alberto; Anzueto, Antonio; Kerwin, Edward M.; Cappelletti, Christy; Duncan, Elizabeth A.; Nyberg, Jack; Dorinsky, Paul Journal: European respiratory journal Issue: Volume 52:Issue 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chronic obstructive pulmonary disease in the long-term care setting: current practices, challenges, and unmet needs. (November 2017) Authors: Suarez-Barcelo, Manuel; Micca, Joseph L.; Clackum, Sharon; Ferguson, Gary T. Journal: Current opinion in pulmonary medicine Issue: Volume 23:Supplement 1(2017.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease. Issue 6 (18th August 2018) Authors: Ferguson, Gary T.; Dalby, Richard N. Journal: Postgraduate medicine Issue: Volume 130:Issue 6(2018) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases. (January 2018) Authors: Ferguson, Gary T.; Hickey, Anthony J.; Dwivedi, Sarvajna Journal: Respiratory medicine Issue: Volume 134(2018) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy. (2nd September 2020) Authors: Calverley, Peter M. A.; Hoz, Alberto de la; Xue, Wenqiong; Ferguson, Gary T.; Miravitlles, Marc Journal: COPD Issue: Volume 17:Number 5(2020) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study. (November 2017) Authors: Ferguson, Gary T.; Tashkin, Donald P.; Skärby, Tor; Jorup, Carin; Sandin, Kristina; Greenwood, Michael; Pemberton, Kristine; Trudo, Frank Journal: Respiratory medicine Issue: Volume 132(2017) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of glycopyrrolate/eFlow® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials. (November 2017) Authors: Kerwin, Edward; Donohue, James F.; Goodin, Thomas; Tosiello, Robert; Wheeler, Alistair; Ferguson, Gary T. Journal: Respiratory medicine Issue: Volume 132(2017) Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗